{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:57:41Z","timestamp":1773485861399,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1007\/s11910-004-0039-z","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T13:39:05Z","timestamp":1180705145000},"page":"196-204","source":"Crossref","is-referenced-by-count":38,"title":["Leptomeningeal metastases"],"prefix":"10.1007","volume":"4","author":[{"given":"Alexis","family":"Demopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"39_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02214196","volume":"49","author":"CJ Eberth","year":"1870","unstructured":"Eberth CJ: Zur Entwicklung des Epitheliomas (Cholesteatomas) dur Pia under der Lungs. Virchow\u2019s Arch 1870, 49:51\u201363.","journal-title":"Virchow\u2019s Arch"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jon199552122","volume":"5","author":"G Hayat","year":"1995","unstructured":"Hayat G, Ehsan T, Selhorst JB, Manepali A: Magnetic resonance evidence of perineural metastasis. J Neuroimaging 1995, 5:122\u2013125.","journal-title":"J Neuroimaging"},{"key":"39_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005792-198201000-00005","volume":"61","author":"ST Rosen","year":"1982","unstructured":"Rosen ST, Aisner J, Makuch RW, et al.: Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine 1982, 61:45\u201353.","journal-title":"Medicine"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneur.1974.00490320010002","volume":"30","author":"ME Olson","year":"1974","unstructured":"Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol 1974, 30:122\u2013137.","journal-title":"Arch Neurol"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982, 49:759\u2013772.","journal-title":"Cancer"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","volume":"29","author":"JP Glass","year":"1979","unstructured":"Glass JP, Melamed M, Chernik NL, Posner JB: Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 1979, 29:1369\u20131375.","journal-title":"Neurology"},{"key":"39_CR7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF01476415","volume":"126","author":"N Arita","year":"1994","unstructured":"Arita N, Taneda M, Hayakawa T: Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir (Wien) 1994, 126:84\u201392.","journal-title":"Acta Neurochir (Wien)"},{"key":"39_CR8","first-page":"4674","volume":"9","author":"H Pfeifer","year":"2003","unstructured":"Pfeifer H, Wassmann B, Hofmann WK, et al.: Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. Clin Cancer Res 2003, 9:4674\u20134681.","journal-title":"Clin Cancer Res"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1096-911X(199702)28:2<98::AID-MPO3>3.0.CO;2-N","volume":"28","author":"AI Freeman","year":"1997","unstructured":"Freeman AI, Boyett JM, Glicksman AS, et al.: Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up. Med Pediatr Oncol 1997, 28:98\u2013107.","journal-title":"Med Pediatr Oncol"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1015018808804","volume":"56","author":"C Kosmas","year":"2002","unstructured":"Kosmas C, Malamos NA, Tsavaris NB, et al.: Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer. J Neurooncol 2002, 56:265\u2013273. Important study.","journal-title":"J Neurooncol"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1011132609055","volume":"12","author":"D Crivellari","year":"2001","unstructured":"Crivellari D, Pagani O, Veronesi A, et al., for the International Breast Cancer Study Group: High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol 2001, 12:353\u2013356.","journal-title":"Ann Oncol"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/cncr.11436","volume":"97","author":"JC Bendell","year":"2003","unstructured":"Bendell JC, Domchek SM, Burstein HJ, et al.: Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 2003, 97:2972\u20132977. Important study.","journal-title":"Cancer"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1227\/00006123-199510000-00008","volume":"37","author":"IF Pollack","year":"1995","unstructured":"Pollack IF, Gerszten PC, Martinez AJ, et al.: Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995, 37:655\u2013666; discussion 666\u2013667.","journal-title":"Neurosurgery"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410380212","volume":"38","author":"C Balmaceda","year":"1995","unstructured":"Balmaceda C, Gaynor JJ, Sun M, et al.: Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol 1995, 38:202\u2013209.","journal-title":"Ann Neurol"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1200\/JCO.1999.17.10.3234","volume":"17","author":"M Fouladi","year":"1999","unstructured":"Fouladi M, Gajjar A, Boyett JM, et al.: Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 1999, 17:3234\u20133237.","journal-title":"J Clin Oncol"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0360-3016(98)00560-4","volume":"44","author":"E Chow","year":"1999","unstructured":"Chow E, Reardon DA, Shah AB, et al.: Pediatric choroid plexus neoplasms. Int J Radiat Oncol Biol Phys 1999, 44:249\u2013254.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"39_CR17","first-page":"1122","volume":"21","author":"DM Armao","year":"2000","unstructured":"Armao DM, Stone J, Castillo M, et al.: Diffuse leptomeningeal oligodendrogliomatosis: radiologic\/pathologic correlation. Am J Neuroradiol 2000, 21:1122\u20131126.","journal-title":"Am J Neuroradiol"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00381-003-0733-1","volume":"19","author":"G Perilongo","year":"2003","unstructured":"Perilongo G, Garre ML, Giangaspero F: Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv Syst 2003, 19:197\u2013203. Important study.","journal-title":"Childs Nerv Syst"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1215\/S1152851702000297","volume":"5","author":"J Hukin","year":"2003","unstructured":"Hukin J, Siffert J, Cohen H, et al.: Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors. Neuro-oncol 2003, 5:188\u2013196.","journal-title":"Neuro-oncol"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1023983518341","volume":"63","author":"H Endo","year":"2003","unstructured":"Endo H, Kumabe T, Jokura H, et al.: Leptomeningeal dissemination of cerebellar malignant astrocytomas. J Neurooncol 2003, 63:191\u2013199.","journal-title":"J Neurooncol"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jnnp.66.2.225","volume":"66","author":"TC Ree van der","year":"1999","unstructured":"van der Ree TC, Dippel DW, Avezaat CJ, et al.: Leptomeningeal metastasis after surgical resection of brain metastases. J Neurol Neurosurg Psychiatry 1999, 66:225\u2013227.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2003.11.141","volume":"21","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Mughal TI, et al., for the International Extranodal Lymphoma Study Group: Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003, 21:20\u201327.","journal-title":"J Clin Oncol"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0360-3016(01)02647-5","volume":"52","author":"A Zouhair","year":"2002","unstructured":"Zouhair A, Weber D, Belkacemi Y, et al., for the Rare Cancer Network: Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2002, 52:652\u2013656.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.LAB.0000036876.08970.C1","volume":"82","author":"D Brandsma","year":"2002","unstructured":"Brandsma D, Reijneveld JC, Taphoorn MJ, et al.: Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeninges. Lab Invest 2002, 82:1493\u20131502.","journal-title":"Lab Invest"},{"key":"39_CR25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.44.8.1463","volume":"44","author":"T Siegal","year":"1994","unstructured":"Siegal T, Lossos A, Pfeffer MR: Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology 1994, 44:1463\u20131469.","journal-title":"Neurology"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0009-9260(99)91181-9","volume":"54","author":"DA Collie","year":"1999","unstructured":"Collie DA, Brush JP, Lammie GA, et al.: Imaging features of leptomeningeal metastases. Clin Radiol 1999, 54:765\u2013771.","journal-title":"Clin Radiol"},{"key":"39_CR27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s004150050459","volume":"246","author":"CS Straathof","year":"1999","unstructured":"Straathof CS, de Bruin G, Dippel DW, Vecht CJ: The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 1999, 246:810\u2013814.","journal-title":"J Neurol"},{"key":"39_CR28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2214\/ajr.181.2.1810591","volume":"181","author":"AD Olsan","year":"2003","unstructured":"Olsan AD, Milburn JM, Baumgarten KL, Durham HL: Leptomeningeal enhancement in a patient with proven West Nile virus infection. Am J Roentgenol 2003, 181:591\u2013592.","journal-title":"Am J Roentgenol"},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/01.WNL.0000063320.61458.D8","volume":"60","author":"AW Hsia","year":"2003","unstructured":"Hsia AW, Katz JS, Hancock SL, Peterson K: Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI. Neurology 2003, 60:1694\u20131696.","journal-title":"Neurology"},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08880010390158513","volume":"20","author":"F Fasipe","year":"2003","unstructured":"Fasipe F, Bestak M, Green NS: Recurrent central nervous system acute lymphoblastic leukemia associated with cerebrospinal fluid eosinophilia and basophilia: a proposed cytokine-mediated mechanism. Pediatr Hematol Oncol 2003, 20:31\u201337.","journal-title":"Pediatr Hematol Oncol"},{"key":"39_CR31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","volume":"82","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Glantz LK, et al.: Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 1998, 82:733\u2013739.","journal-title":"Cancer"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/neuonc\/3.1.42","volume":"3","author":"MC Chamberlain","year":"2001","unstructured":"Chamberlain MC, Kormanik PA, Glantz MJ: A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases. Neuro-oncol 2001, 3:42\u201345.","journal-title":"Neuro-oncol"},{"key":"39_CR33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.5858\/2000-124-0759-DVOIIL","volume":"124","author":"JE Thomas","year":"2000","unstructured":"Thomas JE, Falls E, Velasco ME, Zaher A: Diagnostic value of immunocytochemistry in leptomeningeal tumor dissemination. Arch Pathol Lab Med 2000, 124:759\u2013761.","journal-title":"Arch Pathol Lab Med"},{"key":"39_CR34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00149379","volume":"7","author":"A Twijnstra","year":"1989","unstructured":"Twijnstra A, Ongerboer de Visser BW, van Zanten AP, et al.: Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. J Neurooncol 1989, 7:57\u201363.","journal-title":"J Neurooncol"},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ajcp\/88.5.570","volume":"88","author":"ES Cibas","year":"1987","unstructured":"Cibas ES, Malkin MG, Posner JB, Melamed MR: Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 1987, 88:570\u2013577.","journal-title":"Am J Clin Pathol"},{"key":"39_CR36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4","volume":"77","author":"CH Rhodes","year":"1996","unstructured":"Rhodes CH, Glantz MJ, Glantz L, et al.: A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996, 77:543\u2013548.","journal-title":"Cancer"},{"key":"39_CR37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00019606-200309000-00002","volume":"12","author":"CA Scrideli","year":"2003","unstructured":"Scrideli CA, Queiroz RP, Takayanagui OM, et al.: Polymerase chain reaction on cerebrospinal fluid cells in suspected leptomeningeal involvement in childhood acute lymphoblastic leukemia: comparison to cytomorphological analysis. Diagn Mol Pathol 2003, 12:124\u2013127. Important study.","journal-title":"Diagn Mol Pathol"},{"key":"39_CR38","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M","volume":"67","author":"W Boogerd","year":"1991","unstructured":"Boogerd W, Hart AA, van der Sande JJ, Engelsman E: Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 1991, 67:1685\u20131695.","journal-title":"Cancer"},{"key":"39_CR39","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","volume":"82","author":"F Bokstein","year":"1998","unstructured":"Bokstein F, Lossos A, Siegal T: Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 1998, 82:1756\u20131763.","journal-title":"Cancer"},{"key":"39_CR40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","volume":"293","author":"WR Shapiro","year":"1975","unstructured":"Shapiro WR, Young DF, Mehta BM: Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975, 293:161\u2013166.","journal-title":"N Engl J Med"},{"key":"39_CR41","first-page":"49","volume":"47","author":"DI Sandberg","year":"2000","unstructured":"Sandberg DI, Bilsky MH, Souweidane MM, et al.: Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 2000, 47:49\u201354; discussion 54\u201355. Important study.","journal-title":"Neurosurgery"},{"key":"39_CR42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","volume":"50","author":"WP Mason","year":"1998","unstructured":"Mason WP, Yeh SD, DeAngelis LM: 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1998, 50:438\u2013444.","journal-title":"Neurology"},{"key":"39_CR43","first-page":"611","volume":"24","author":"MR Pfeffer","year":"1988","unstructured":"Pfeffer MR, Wygoda M, Siegal T: Leptomeningeal metastases-treatment results in 98 consecutive patients. Israel J Med Sci 1988, 24:611\u2013618.","journal-title":"Israel J Med Sci"},{"key":"39_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02327385","volume":"6","author":"WT Sause","year":"1988","unstructured":"Sause WT, Crowley J, Eyre HJ, et al.: Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases-a Southwest Oncology Group study. J Neuro-oncol 1988, 6:107\u2013112.","journal-title":"J Neuro-oncol"},{"key":"39_CR45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002800000173","volume":"46","author":"FJ Esteva","year":"2000","unstructured":"Esteva FJ, Soh LT, Holmes FA, et al.: Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer. Cancer Chemother Pharmacol 2000, 46:382\u2013386.","journal-title":"Cancer Chemother Pharmacol"},{"key":"39_CR46","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, et al.: Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999, 17:3110\u20133116.","journal-title":"J Clin Oncol"},{"key":"39_CR47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ: Leptomeningeal carcinomatosis. Cancer Treat Rev 1999, 25:103\u2013119.","journal-title":"Cancer Treat Rev"},{"key":"39_CR48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00043426-200205000-00011","volume":"24","author":"PG Fisher","year":"2002","unstructured":"Fisher PG, Kadan-Lottick NS, Korones DN: Intrathecal thiotepa: reappraisal of an established therapy. J Pediatr Hematol Oncol 2002, 24:274\u2013278. A careful study that clarifies the prior treatment success seen with this modality.","journal-title":"J Pediatr Hematol Oncol"},{"key":"39_CR49","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.55.4.506","volume":"55","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC, Kormanik P: Carcinomatous meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 1998, 55:506\u2013512.","journal-title":"Arch Neurol"},{"key":"39_CR50","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/1097-0142(20010501)91:9<1809::AID-CNCR1200>3.0.CO;2-L","volume":"91","author":"I Cokgor","year":"2001","unstructured":"Cokgor I, Akabani G, Friedman HS, et al.: Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab\u2019)(2): a case study. Cancer 2001, 91:1809\u20131813.","journal-title":"Cancer"},{"key":"39_CR51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/hum.1995.6.1-55","volume":"6","author":"EH Oldfield","year":"1995","unstructured":"Oldfield EH, Ram Z, Chiang Y, Blaese RM: Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI 0108. A phase I\/II study. Hum Gene Ther 1995, 6:55\u201359.","journal-title":"Hum Gene Ther"},{"key":"39_CR52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3171\/jns.1995.82.1.0070","volume":"82","author":"JJ Viola","year":"1995","unstructured":"Viola JJ, Ram Z, Walbridge S, et al.: Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J Neurosurg 1995, 82:70\u201376.","journal-title":"J Neurosurg"},{"key":"39_CR53","first-page":"2646","volume":"5","author":"GE Archer","year":"1999","unstructured":"Archer GE, Sampson JH, Lorimer IA, et al.: Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1. Clin Cancer Res 1999, 5:2646\u20132652.","journal-title":"Clin Cancer Res"},{"key":"39_CR54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","volume":"101","author":"JL Rubenstein","year":"2003","unstructured":"Rubenstein JL, Combs D, Rosenberg J, et al.: Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 2003, 101:466\u2013468.","journal-title":"Blood"},{"key":"39_CR55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002800000118","volume":"46","author":"ML Tetef","year":"2000","unstructured":"Tetef ML, Margolin KA, Doroshow JH, et al.: Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Cancer Chemother Pharmacol 2000, 46:19\u201322. Important study.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-004-0039-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0039-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T13:11:30Z","timestamp":1628946690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-004-0039-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s11910-004-0039-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}